Edition:
United Kingdom

Reckitt Benckiser Group PLC (RB.L)

RB.L on London Stock Exchange

6,583.00GBp
4:45pm BST
Change (% chg)

-60.00 (-0.90%)
Prev Close
6,643.00
Open
6,699.00
Day's High
6,712.00
Day's Low
6,579.00
Volume
1,061,701
Avg. Vol
1,417,671
52-wk High
7,174.00
52-wk Low
5,559.00

Latest Key Developments (Source: Significant Developments)

Reckitt Benckiser To Pay $1.4 Bln To Resolve All Federal Investigations
Thursday, 11 Jul 2019 

July 11 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER GP - AGREEMENT TO RESOLVE ALL FEDERAL INVESTIGATIONS.RECKITT BENCKISER GROUP PLC - TERMS OF AGREEMENTS, RB WILL PAY A TOTAL OF UP TO $1.4 BILLION TO FULLY RESOLVE ALL FEDERAL INVESTIGATIONS.RECKITT BENCKISER GROUP PLC - SETTLEMENT AMOUNT WILL BE FUNDED THROUGH EXISTING BORROWING FACILITIES AND CASH GENERATION.RECKITT BENCKISER GROUP PLC - RB HAS A PROVISION OF $400 MILLION AND WILL INCREASE ITS PROVISION TO $1.5 BILLION AT ITS HALF-YEAR RESULTS.RECKITT BENCKISER GROUP PLC - BOARD OF RB DETERMINED THAT "AGREEMENT IS IN BEST INTERESTS OF COMPANY AND ITS SHAREHOLDERS".RECKITT BENCKISER GROUP PLC - RB BELIEVES PROVISION WILL COVER SETTLEMENT AND ANY REMAINING LITIGATION EXPOSURES.RECKITT - AGREEMENTS WITH U.S. DOJ, FTC TO RESOLVE INVESTIGATION INTO SALES AND MARKETING OF SUBOXONE FILM BY INDIVIOR.RECKITT BENCKISER GROUP - "BOARD OF RB DETERMINED THAT AGREEMENT IS IN BEST INTERESTS OF COMPANY AND ITS SHAREHOLDERS".RECKITT - SETTLEMENT IS NON-CRIMINAL RESOLUTION; ON BASIS THAT THERE IS NO ADMISSION OF VIOLATION OF LAW OR ANY WRONGDOING BY RB OR ANY RB EMPLOYEE.RECKITT BENCKISER GROUP - RESOLUTION WILL ALSO PROTECT GROUP'S PARTICIPATION IN ALL U.S. GOVERNMENT PROGRAMMES.  Full Article

Reckitt Chairman says CEO search "well underway"
Thursday, 9 May 2019 

May 9 (Reuters) - Reckitt Benckiser Group PLC ::RECKITT BENCKISER CHAIRMAN SAYS COMPANY CONTINUES TO ACTIVELY PURSUE M&A OPPORTUNITIES - AGM.RECKITT BENCKISER CHAIRMAN SAYS COMPANY IS "WELL UNDERWAY" WITH COMPREHENSIVE PROCESS TO SELECT CEO SUCCESSOR.RECKITT BENCKISER CHAIRMAN SAYS HOPEFUL COMPANY WILL BE ABLE TO NAME CEO SUCCESSOR IN "NOT TOO DISTANT FUTURE".  Full Article

Reckitt Benckiser Sees Improving Growth In Remainder Of Year After Slow Q1
Thursday, 2 May 2019 

May 2 (Reuters) - Reckitt Benckiser Group PLC ::Q1 TOTAL SALES 3,157 MILLION STG VERSUS 3,111 MILLION STG AS REPORTED A YEAR EARLIER.RB2.0 REMAINS ON TRACK..REMAIN ON TRACK FOR FULL YEAR NET REVENUE TARGET OF +3-4% LFL WITH GROWTH TO BE H2 WEIGHTED..EXPECT TO SEE IMPROVING GROWTH IN REMAINDER OF YEAR, PARTICULARLY IN H2.REITERATE 2019 TARGETS OF +3-4% LFL NET REVENUE GROWTH AND ADJUSTED(1) OPERATING MARGIN TO BE MAINTAINED.RECKITT BENCKISER, ON INDIVIOR/RB PHARMA-RELATED MATTERS, SAYS REMAINS INVOLVED IN ONGOING INVESTIGATIONS BY US DOJ, US FEDERAL TRADE COMMISSION.MAY INCUR LIABILITIES IN RELATION TO MATTERS RELATING TO INDIVIOR / RB PHARMA-RELATED LITIGATION MATTERS.ONGOING INVESTIGATIONS REFERS TO MATTERS RELATING TO RB PHARMACEUTICALS BUSINESS PRIOR TO ITS DEMERGER IN DECEMBER 2014 TO FORM INDIVIOR.FINAL COST ON RESOLVING INDIVIOR / RB PHARMA-RELATED LITIGATION MATTERS MAY BE SUBSTANTIALLY HIGHER THAN THIS PROVISION.  Full Article

Clorox Files False-Advertising Lawsuit Against The Maker Of Lysol
Wednesday, 20 Mar 2019 

Clorox Co ::CLOROX FILES FALSE-ADVERTISING LAWSUIT AGAINST THE MAKER OF LYSOL.CLOROX - FILED LAWSUIT AGAINST RECKITT BENCKISER IN RESPONSE TO A WIDE-RANGING ADVERTISING CAMPAIGN FOR RB'S LYSOL BRAND.CLOROX - ACCORDING TO LAWSUIT, RECKITT BENCKISER'S CAMPAIGN IS DESIGNED TO "MISLEAD CONSUMERS TO PURCHASE" RECKITT'S PRODUCTS INSTEAD OF CO'S PRODUCTS.  Full Article

Petiq, Inc. Appoints Animal Health Executive Susan Sholtis As President
Wednesday, 19 Sep 2018 

Sept 19 (Reuters) - PetIQ Inc ::PETIQ, INC. APPOINTS PROVEN MULTINATIONAL ANIMAL HEALTH EXECUTIVE SUSAN SHOLTIS AS PRESIDENT.PETIQ INC - APPOINTED SUSAN SHOLTIS AS PRESIDENT, EFFECTIVE OCTOBER 1, 2018.PETIQ INC - SHOLTIS WILL SIMULTANEOUSLY RESIGN FROM HER DUTIES AS A MEMBER ON COMPANY'S BOARD.PETIQ INC - SHOLTIS HAS SERVED AS A GLOBAL MARKETING HEAD IN HEALTH DIVISION AT RECKITT BENCKISER SINCE 2017.  Full Article

Jab Holdings Cuts Stake To 2.97 Pct In Reckitt Benckiser
Wednesday, 8 Aug 2018 

Aug 8 (Reuters) - Reckitt Benckiser Group PLC ::JAB HOLDINGS B.V. CUTS STAKE TO 2.97 PERCENT FROM 3.68 PERCENT IN RECKITT BENCKISER GROUP PLC - FILING.  Full Article

Reckitt CEO bullish on consumer health, no comment on Pfizer
Monday, 19 Feb 2018 

Feb 19 (Reuters) - Reckitt Benckiser Group Plc ::RECKITT BENCKISER CEO SAYS NO COMMENT ON PFIZER CONSUMER HEALTH AUCTION.RECKITT BENCKISER CEO SAYS ACQUISITIONS MUST BE STRATEGICALLY COMPELLING, RB MUST BE A BETTER OWNER, AND MUST DRIVE VALUE FOR SHAREHOLDERS.RECKITT BENCKISER CEO SAYS CONFIDENT ABOUT GROWTH OF CONSUMER HEALTH CATEGORY IN LONG TERM.  Full Article

Reckitt Benckiser Says Targeting 13-14 Pct Total Revenue Growth For 2018 ​
Monday, 19 Feb 2018 

Feb 19 (Reuters) - Reckitt Benckiser Group Plc ::FINAL DIVIDEND 97.7 PENCE PER SHARE.FY ADJUSTED DILUTED EPS ROSE 10 PERCENT TO 316.9 PENCE.FY ‍TOTAL OPERATIONS (INCLUDING DISCONTINUED OPERATIONS) ADJ DILUTED EPS OF 324.6 PENCE ​.TOTAL DIVIDEND 164.3 PENCE PER SHARE.FY REVENUE 11.51 BILLION STG.Q4 NET REVENUE ‍3,289 MILLION POUNDS, +25%​.‍+2% LIKE-FOR-LIKE NET REVENUE GROWTH IN Q4​.‍FY FLAT LFL NET REVENUE IN LINE WITH GUIDANCE​.‍FY TOTAL GROUP ADJUSTED OPERATING MARGIN OF -70BPS TO 27.1%​.FY ADJUSTED NET INCOME ‍2,253 MILLION POUNDS, +10%​.‍FY REPORTED DILUTED EPS OF 867.9P​.‍FREE CASH FLOW GENERATION OF £2,129M IN FY ​.‍FOR 2018 TARGETING +13-14% TOTAL REVENUE GROWTH​."‍WHILST 2018 WILL SEE SOME SPECIFIC FACTORS IMPACTING MARGIN, REITERATE MEDIUM-TERM TARGET OF MODERATE OPERATING MARGIN EXPANSION​".ON ‍MJN COST SYNERGIES, EXPECTING TO ACHIEVE IN REGION OF $300M IN ANNUAL COST SAVINGS BY END OF THIRD FULL YEAR OF OWNERSHIP.‍FOR 2018, EXPECT MJN COST SYNERGIES TO SLIGHTLY EXCEED ADDITIONAL INFRASTRUCTURE COSTS ASSOCIATED WITH NEW BUS​.  Full Article

Reckitt Benckiser CEO comments
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Reckitt Benckiser Group Plc :Reckitt benckiser ceo says seeing subdued growth in developed and developing markets.Reckitt benckiser ceo says health unit to have sales of around 7.5 billion pounds, with hygiene/home sales around 5 billion.Reckitt benckiser ceo says too early to discuss 2018 forecast.Reckitt benckiser ceo says both business units to have marketing directors and has announced executive line-up.  Full Article

JAB Holdings discloses 6.69 pct stake in Reckitt Benckiser - filing
Tuesday, 3 Oct 2017 

Oct 3 (Reuters) - Regulatory Filing::JAB HOLDINGS B.V. DISCLOSES 6.69 PERCENT STAKE IN RECKITT BENCKISER GROUP PLC - REGULATORY FILING.  Full Article

Takeda kicks off sale of Western European drugs - sources

FRANKFURT/LONDON, July 17 Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in western Europe as it seeks to trim its debt following the $59 billion purchase of Shire, sources close to the matter told Reuters.